Research-stage investigational psilocybin pharmacology and cannabinoid hybrid scaffold exploring multi-pathway recovery biology in the context of prolonged neurological dysregulation. Intended to support study of circuit-state endpoints including plasticity markers, neuroimmune readouts, and stress/reward pathway biomarkers.
